Barbara P. Sanders

Science Park 408
Amsterdam, NH 1098XH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Plug-in hybrid baculovirus expression vector for high-yield recombinant adeno-associated virus gene therapy vector production.

Plug-in hybrid baculovirus expression vector for high-yield recombinant adeno-associated virus gene therapy vector production.

Journal: Trends in biotechnology

Published: March 13, 2026

Productivity and genetic stability of a novel baculovirus vector for multigene expression from independent transgene loci.

Productivity and genetic stability of a novel baculovirus vector for multigene expression from independent transgene loci.

Journal: Molecular therapy. Advances

Published: October 20, 2025

A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing.

A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing.

Journal: Vaccine

Published: February 07, 2018

Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response.

Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response.

Journal: Human gene therapy

Published: August 18, 2017

Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.

Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.

Journal: PLoS pathogens

Published: September 14, 2015

Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.

Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.

Journal: Vaccine

Published: September 01, 2015

Synthetic virus seeds for improved vaccine safety: Genetic reconstruction of poliovirus seeds for a PER.C6 cell based inactivated poliovirus vaccine.

Synthetic virus seeds for improved vaccine safety: Genetic reconstruction of poliovirus seeds for a PER.C6 cell based inactivated poliovirus vaccine.

Journal: Vaccine

Published: July 03, 2015

Brunenders: a partially attenuated historic poliovirus type I vaccine strain.

Brunenders: a partially attenuated historic poliovirus type I vaccine strain.

Journal: The Journal of general virology

Published: May 29, 2015

PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.

PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.

Journal: Vaccine

Published: July 23, 2012

Caregiver characteristics and economic cost of home-based care: a case study of Maun and Gumare villages in North West District, Botswana.

Caregiver characteristics and economic cost of home-based care: a case study of Maun and Gumare villages in North West District, Botswana.

Journal: Chronic illness

Published: June 27, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026